 |
|
Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational
cohort study
Seng Chan You, Hojun Park, Dukyong Yoon, Sooyoung Park, Boyoung Joung, Rae Woong Park
Korean J Intern Med. 2019;34(1):90-98. Published online 2017 Nov 27 DOI: https://doi.org/10.3904/kjim.2017.002
|
|
Citations to this article as recorded by
 Angiotensin Receptor Blocker–Related Sprue-like Enteropathy: Review of Food and Drug Administration Adverse Event Reporting System
Ryan Meader, Sam Papasotiriou, Hardeep Ahdi, Hoang Dang, Eli D. Ehrenpreis
Annals of Pharmacotherapy.2024; 58(5): 494. CrossRef Chronic diarrhoea, weight loss and a positive anti-tissue transglutaminase antibody: A case report of olmesartan-induced enteropathy
Rachel Sheppard, Benjamin Evanson, Iona Campbell, Alan Shand
BMJ Case Reports.2024; 17(5): e255407. CrossRef Refractory Celiac Disease: What the Gastroenterologist Should Know
Mariana Verdelho Machado
International Journal of Molecular Sciences.2024; 25(19): 10383. CrossRef A Rare Case of Olmesartan-Associated Enteropathy Successfully Managed With Steroid Taper
Angela Xue, Mark R Fowler, Jan Silverman, Emily Sturkie, Evan Raff
Cureus.2023;[Epub] CrossRef A Prospective Randomized, Double-Blind, Multi-Center, Phase III Clinical Trial Evaluating the Efficacy and Safety of Olmesartan/Amlodipine plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia: A LEISURE Study
Sang-Ho Jo, Seok Min Kang, Byung Su Yoo, Young Soo Lee, Ho Joong Youn, Kyungwan Min, Jae Myung Yu, Hyun Ju Yoon, Woo Shik Kim, Gee Hee Kim, Jae Hyoung Park, Seok Yeon Kim, Cheol Ho Kim
Journal of Clinical Medicine.2022; 11(2): 350. CrossRef Olmesartan-associated Enteropathy with Acute Kidney Injury
Moo Jin Kang, Kyung Hwa Min, Hyung Wook Kim, Su Bum Park, Dae Hwan Kang, Cheol Woong Choi, Su Jin Kim, Hyeong Seok Nam, Dae Gon Ryu
The Korean Journal of Gastroenterology.2022; 79(3): 130. CrossRef A Case of Sprue-like Enteropathy Associated With Valsartan and Irbesartan
Seo Yeon Yoo, Jihun Kim, Kee Wook Jung
Journal of Neurogastroenterology and Motility.2022; 28(2): 327. CrossRef Severe cases of sprue‐like enteropathy associated with angiotensin receptor blockers other than olmesartan
Peter Malfertheiner, Chiara Formigoni
GastroHep.2021; 3(2): 88. CrossRef An unusual cause of diarrhoea: case report and literature review of olmesartan-associated enteropathy
Paula Antonia Mauloni, Federica Capuani, Clara Paone, Giovanni Marasco, Lara Bellacosa, Rosanna Francesca Cogliandro, Cesare Cremon, Giovanni Barbara, Francesco Vasuri, Vincenzo Stanghellini
European Journal of Gastroenterology & Hepatology.2021; 33(1S): e1060. CrossRef Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review
Ayesha Kamal, Christopher Fain, Angela Park, Peiqi Wang, Eduardo Gonzalez-Velez, Daniel A Leffler, Susan M Hutfless
Gastroenterology Report.2019; 7(3): 162. CrossRef Association of sprue-like enteropathy and angiotensin receptor-1 antagonists
René R. Wenzel, Christian Datz
Wiener klinische Wochenschrift.2019; 131(19-20): 493. CrossRef Traitement par olmésartan et entéropathie : à propos de deux cas et revue de la littérature
A. Sadki, M. Le Besnerais, F. Héron, I. Marie
La Revue de Médecine Interne.2018;[Epub] CrossRef
|